Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
clinical trials
Pharma
InflaRx scraps vilobelimab study in rare skin disorder
After a poor showing of its COVID med vilobelimab in a rare skin disorder trial, German drugmaker InflaRx is going back to the drawing board.
Fraiser Kansteiner
May 28, 2025 9:55am
Fierce's forecasts for the next year in biopharma
Jan 17, 2025 8:45am
More testing needed after Moderna trial halted by FDA: experts
Dec 13, 2024 8:15am
Lawmakers spotlight studies run at China military hospitals
Aug 20, 2024 2:34pm
What's in a name? Inside the process of naming clinical trials
May 14, 2024 4:39pm
Charles River to help Navega produce gene therapy candidate
Mar 14, 2024 9:50am
